Literature DB >> 24680984

Formalizing MedDRA to support semantic reasoning on adverse drug reaction terms.

Cédric Bousquet1, Éric Sadou2, Julien Souvignet1, Marie-Christine Jaulent2, Gunnar Declerck3.   

Abstract

Although MedDRA has obvious advantages over previous terminologies for coding adverse drug reactions and discovering potential signals using data mining techniques, its terminological organization constrains users to search terms according to predefined categories. Adding formal definitions to MedDRA would allow retrieval of terms according to a case definition that may correspond to novel categories that are not currently available in the terminology. To achieve semantic reasoning with MedDRA, we have associated formal definitions to MedDRA terms in an OWL file named OntoADR that is the result of our first step for providing an "ontologized" version of MedDRA. MedDRA five-levels original hierarchy was converted into a subsumption tree and formal definitions of MedDRA terms were designed using several methods: mappings to SNOMED-CT, semi-automatic definition algorithms or a fully manual way. This article presents the main steps of OntoADR conception process, its structure and content, and discusses problems and limits raised by this attempt to "ontologize" MedDRA.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse drug reaction; MedDRA; Ontology; SNOMED-CT; Semantic reasoning; Terminology

Mesh:

Year:  2014        PMID: 24680984     DOI: 10.1016/j.jbi.2014.03.012

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  7 in total

1.  Computational approaches for pharmacovigilance signal detection: toward integrated and semantically-enriched frameworks.

Authors:  Vassilis G Koutkias; Marie-Christine Jaulent
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

2.  ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms.

Authors:  Mei-Chun Cai; Quan Xu; Yan-Jing Pan; Wen Pan; Nan Ji; Yin-Bo Li; Hai-Jing Jin; Ke Liu; Zhi-Liang Ji
Journal:  Nucleic Acids Res       Date:  2014-10-31       Impact factor: 16.971

3.  Dione: An OWL representation of ICD-10-CM for classifying patients' diseases.

Authors:  María Del Mar Roldán-García; María Jesús García-Godoy; José F Aldana-Montes
Journal:  J Biomed Semantics       Date:  2016-10-13

4.  Medication-related visits in a pediatric emergency department: an 8-years retrospective analysis.

Authors:  Cristiano Rosafio; Serena Paioli; Cinzia Del Giovane; Valentina Cenciarelli; Nilla Viani; Paolo Bertolani; Lorenzo Iughetti
Journal:  Ital J Pediatr       Date:  2017-06-13       Impact factor: 2.638

5.  Good Signal Detection Practices: Evidence from IMI PROTECT.

Authors:  Antoni F Z Wisniewski; Andrew Bate; Cedric Bousquet; Andreas Brueckner; Gianmario Candore; Kristina Juhlin; Miguel A Macia-Martinez; Katrin Manlik; Naashika Quarcoo; Suzie Seabroke; Jim Slattery; Harry Southworth; Bharat Thakrar; Phil Tregunno; Lionel Van Holle; Michael Kayser; G Niklas Norén
Journal:  Drug Saf       Date:  2016-06       Impact factor: 5.606

6.  OpenPVSignal: Advancing Information Search, Sharing and Reuse on Pharmacovigilance Signals via FAIR Principles and Semantic Web Technologies.

Authors:  Pantelis Natsiavas; Richard D Boyce; Marie-Christine Jaulent; Vassilis Koutkias
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810

7.  Associations between certolizumab pegol serum levels, anti-drug antibodies and treatment response in patients with inflammatory joint diseases: data from the NOR-DMARD study.

Authors:  Johanna Elin Gehin; Guro Løvik Goll; David John Warren; Silje Watterdal Syversen; Joseph Sexton; Eldri Kveine Strand; Tore Kristian Kvien; Nils Bolstad; Elisabeth Lie
Journal:  Arthritis Res Ther       Date:  2019-11-29       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.